Results 221 to 230 of about 2,242,237 (349)
Digital twins to accelerate target identification and drug development for immune‐mediated disorders
Digital twins integrate patient‐derived molecular and clinical data into personalised computational models that simulate disease mechanisms. They enable rapid identification and validation of therapeutic targets, prediction of drug responses, and prioritisation of candidate interventions.
Anna Niarakis, Philippe Moingeon
wiley +1 more source
Contrastive learning-based multi-mechanism disentangled assessment for drug-drug interaction. [PDF]
Zhang J +5 more
europepmc +1 more source
This paper reveals how human lactoferrin–albumin fusion (hLF‐HSA) potently suppresses lung adenocarcinoma cell migration. hLF‐HSA upregulates NHE7, leading to Golgi alkalization, disruption of the Golgi secretome, downregulation of MMP1, and reversal of EMT. These findings suggest a novel Golgi‐targeting strategy to suppress cancer cell migration.
Hana Nopia +3 more
wiley +1 more source
UGT2B7-mediated drug-drug interaction between cannabinoids and hydromorphone. [PDF]
Coates S, Bardhi K, Zhao M, Lazarus P.
europepmc +1 more source
Chemotherapy side effects significantly impact cancer survivors' quality of life. Using protein levels in blood samples from breast cancer patients before and after 12 weeks of taxane treatment, we detected treatment‐dependent changes in calcium signaling and aging pathways associated with cancer recurrence.
Saira Munshani +6 more
wiley +1 more source
<i>In silico</i> and <i>in vitro</i> investigations of the drug-drug interaction mechanisms between fludarabine and busulfan. [PDF]
Ben Hassine K +7 more
europepmc +1 more source
The MRP4 transporter exports several drugs and signaling molecules. Here, we identified key promoter elements regulating basal MRP4 expression. Using reporter assays, we defined a conserved region with essential Sp1 and contributory Ets sites, which controlled basal MRP4 expression.
Debora Singer +7 more
wiley +1 more source
A Dose-Aware Model for Revealing Dose-Risk Relationship of Drug-Drug Interaction. [PDF]
Shi Y +8 more
europepmc +1 more source

